La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
emeis Société anonyme Performance dei guadagni passati
Il passato criteri di controllo 2/6
emeis Société anonyme's earnings have been declining at an average annual rate of -59.3%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 8.2% per year. emeis Société anonyme's return on equity is 72.1%, and it has net margins of 26.1%.
Informazioni chiave
-59.3%
Tasso di crescita degli utili
-69.3%
Tasso di crescita dell'EPS
| Healthcare Crescita del settore | 12.6% |
| Tasso di crescita dei ricavi | 8.2% |
| Rendimento del capitale proprio | 72.1% |
| Margine netto | 26.1% |
| Prossimo aggiornamento sui guadagni | 04 Oct 2024 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Ripartizione dei ricavi e delle spese
Come emeis Société anonyme guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storia dei guadagni e delle entrate
| Data | Ricavi | Guadagni | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 31 Dec 23 | 5,198 | 1,355 | 0 | 0 |
| 30 Sep 23 | 5,062 | -1,387 | 0 | 0 |
| 30 Jun 23 | 4,926 | -4,128 | 0 | 0 |
| 31 Mar 23 | 4,803 | -4,078 | 0 | 0 |
| 31 Dec 22 | 4,681 | -4,027 | 0 | 0 |
| 30 Sep 22 | 4,602 | -2,167 | 0 | 0 |
| 30 Jun 22 | 4,524 | -307 | 0 | 0 |
| 31 Mar 22 | 4,411 | -121 | 0 | 0 |
| 31 Dec 21 | 4,299 | 65 | 0 | 0 |
| 30 Sep 21 | 4,193 | 127 | 0 | 0 |
| 30 Jun 21 | 4,088 | 189 | 0 | 0 |
| 31 Mar 21 | 4,005 | 175 | 0 | 0 |
| 31 Dec 20 | 3,922 | 160 | 0 | 0 |
| 30 Sep 20 | 3,863 | 176 | 0 | 0 |
| 30 Jun 20 | 3,804 | 192 | 0 | 0 |
| 31 Mar 20 | 3,772 | 213 | 0 | 0 |
| 31 Dec 19 | 3,740 | 234 | 0 | 0 |
| 30 Sep 19 | 3,661 | 231 | 0 | 0 |
| 30 Jun 19 | 3,581 | 227 | 0 | 0 |
| 31 Mar 19 | 3,501 | 224 | 0 | 0 |
| 31 Dec 18 | 3,420 | 220 | 0 | 0 |
| 30 Sep 18 | 3,356 | 230 | 0 | 0 |
| 30 Jun 18 | 3,292 | 239 | 0 | 0 |
| 31 Mar 18 | 3,215 | 164 | 0 | 0 |
| 31 Dec 17 | 3,138 | 90 | 0 | 0 |
| 30 Sep 17 | 3,062 | 133 | 0 | 0 |
| 30 Jun 17 | 2,986 | 176 | 0 | 0 |
| 31 Mar 17 | 2,914 | 235 | 0 | 0 |
| 31 Dec 16 | 2,841 | 294 | 0 | 0 |
| 30 Sep 16 | 2,745 | 220 | 0 | 0 |
| 30 Jun 16 | 2,650 | 147 | 0 | 0 |
| 31 Mar 16 | 2,521 | 137 | 0 | 0 |
| 31 Dec 15 | 2,392 | 127 | 0 | 0 |
| 30 Sep 15 | 2,286 | 128 | 0 | 0 |
| 30 Jun 15 | 2,180 | 130 | 0 | 0 |
| 31 Mar 15 | 2,064 | 126 | 0 | 0 |
| 31 Dec 14 | 1,949 | 121 | 0 | 0 |
| 30 Sep 14 | 1,832 | 112 | 0 | 0 |
| 30 Jun 14 | 1,716 | 103 | 0 | 0 |
| 31 Mar 14 | 1,662 | 108 | 0 | 0 |
| 31 Dec 13 | 1,608 | 114 | 0 | 0 |
Guadagni di qualità: EMEISP has a large one-off gain of €1.9B impacting its last 12 months of financial results to 31st December, 2023.
Margine di profitto in crescita: EMEISP became profitable in the past.
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: EMEISP has become profitable over the past 5 years, growing earnings by -59.3% per year.
Accelerare la crescita: EMEISP has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Guadagni vs Settore: EMEISP has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (17.7%).
Rendimento del capitale proprio
ROE elevato: Whilst EMEISP's Return on Equity (72.05%) is outstanding, this metric is skewed due to their high level of debt.